Circulating levels of GDNF in bipolar disorder

Neuroscience Letters

Volumn 502, Issue 2, 2011, Pages 103-106

  Barbosa, Izabela Guimarães ^a,b   Huguet, Rodrigo Barreto ^a   Sousa, Lirlândia Pires ^a   Abreu, Mery Natali Silva ^a   Rocha, Natália Pessoa ^a   Bauer, Moisés Evandro ^c   Carvalho, Lívia A ^d   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF ROEHAMPTON   (United Kingdom)

Author keywords

Bipolar disorder; GDNF; Glial derived neurotrophic factor; Mood biomarker; Neurotrophic factor

Indexed keywords

ANTICONVULSIVE AGENT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CELL SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MANIA; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NERVE CELL GROWTH; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SUBSTANCE ABUSE; SYNAPSE; YOUNG MANIA RATING SCALE;

ADULT; AFFECT; BIPOLAR DISORDER; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 80051815381     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.031     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Text Revision: DSM-IV-TR 2000, American Psychiatric Press, Washington, DC. fourth ed.
2. Airaksinen M.S. The GDNF family: signaling biological functions and therapeutic value. Nat. Rev. Neurosci. 2002, 3:383-394.
3. Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev. Bras. Psiquiatr. 2000, 22:106-115.
4. Angelucci F., Aloe L., Jiménez-Vasquez P., Mathé A.A. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derive neurotrophic factors and glial cell line-derived neurotrophic factor in a rat model of depression. Int. J. Neuropsychopharmacol. 2003, 6:225-231.
5. Barbosa I.G., Huguet R.B., Mendonça V.A., Neves F.S., Reis H.J., Bauer M.E., Janka Z., Palotás A., Teixeira A.L. Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder. Neurosci. Lett. 2010, 475:95-98.
6. Barbosa I.G., Huguet R.B., Neves F.S., Reis H.J., Bauer M.E., Janka Z., Palotás A., Teixeira A.L. Impaired nerve growth factor homeostasis in patients with bipolar disorder. World J. Biol. Psychiatry 2011, 12:228-232.
7. Belmaker R.H. Bipolar disorder. N. Engl. J. Med. 2004, 351:476-486.
8. Chen P.S., Peng G.S., Li G., Yang S., Wu X., Wang C.C., Wilson B., Lu R.B., Gean P.W., Chuang D.M., Hong J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol. Psychiatry 2006, 11:1116-1125.
9. Ducray A., Krebs S.H., Schaller B., Seiler R.W., Meyer M., Widmer H.R. GDNF-family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res. 2006, 1069:104-112.
10. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
11. Hisaoka K., Takebayashi M., Tsuchioka M., Maeda N., Nakata Y., Yamawaki S. Antidepressants increase glial cell line-derived neurotrophic production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J. Pharmacol. Exp. Ther. 2007, 321:148-157.
12. Kastin A.J., Akerstrom V., Pan W. Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neurosci. Lett. 2003, 340:239-241.
13. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., Kauer-Sant'Anna M., Grassi-Oliveira R., Post R.M. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008, 32:675-692.
14. Kapczinski F., Frey B.N., Kauer-Sant'Anna M., Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev. Neurother. 2008, 8:1101-1113.
15. Lin P.Y. State-dependent decreased in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neurosci. Lett. 2009, 466:139-143.
16. Lundborg C., Hahan-Zoric M., Bilber B., Hansson E. Glial cell line-derived neurotrophic is increased in cerebrospinal fluid but decreased in blood during long-term pain. J. Neuroimmunol. 2010, 220:108-113.
17. Miller C.A. Stress and depressed? Check your GDNF for epigenetic repression. Neuron 2011, 69:188-190.
18. Onodera H., Nagata T., Kanazawa M., Taguma Y., Itoyama Y. Increased plasma GDNF levels in patients with chronic renal diseases. Nephrol. Dial. Transplant. 1999, 14:1604-1605.
19. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., Funato H., Watanabe Y. Altered expression of neurotrophic factor in patients with major depression. J. Psychiatr. Res. 2008, 42:1145-1153.
20. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 2001, 49:741-752.
21. Rosa A.R., Frey B.N., Andreazza A.C., Ceresér K.M., Cunha A.B., Quevedo J., Santin A., Gottfried C., Gonçalves C.A., Vieta E., Kapczinski K. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci. Lett. 2006, 407:146-150.
22. Saavedra A., Baltazar G., Duarte E.P. Driving GDNF expression: the green and red traffic lights. Prog. Neurobiol. 2008, 86:186-215.
23. Schloesser R.J., Huang J., Klein P.S., Manji H.K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008, 33:110-133.
24. Shao Z., Dyck L.E., Wang H., Li X.M. Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. J. Psychiatry Neurosci. 2006, 31:32-37.
25. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar C.G. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:4-57.
26. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., Hikasa S., Okamoto Y., Shinno H., Morinobu S., Yamawaki S. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int. J. Neuropsychopharmacol. 2006, 9:607-612.
27. Teixeira A.L., Barbosa I.G., Diniz B.S., Kummer A. Circulating levels of brain-derived neurotrophic factors: correlation with mood, cognition and motor function. Biomarkers Med. 2010, 4:871-887.
28. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
29. Zhang X., Zhang Z., Xie C., Xi G., Zhou H., Zhang Y., Sha W. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:86-90.
30. Zhang X., Zhang Z., Sha W., Xie C., Xi G., Zhou H., Zhang Y. Eletroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Res. 2009, 170:273-275.
31. Zhang X., Zang Z., Sha W., Xie C., Xi G., Zhou H., Zhang Y. Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. J. Affect. Disord. 2010, 126:326-329.